Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Medical and Pediatric Oncology|January 1, 1980
Cis-platinum therapy of previously treated head and neck cancer: the Southwest Oncology Group's two-dose-per-month outpatient regimenF J Panettiere, D Lehane, W S Fletcher, et al.
Journal of Surgical Oncology|January 1, 1975
A clinical trial of CCNU (1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea) (NSC 79037) in advanced ovarian carcinomaT M Sasaki, D B McConnell, H S Moseley, et al.
American Journal of Clinical Oncology|October 1, 1988
Evaluation of cis-platinum and DTIC combination chemotherapy in disseminated melanoma. A Southwest Oncology Group StudyW S Fletcher, S Green, J R Fletcher, et al.
Cancer Treatment Reports|June 1, 1985
Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group StudyW E Grose, D E Lehane, D O Dixon, et al.
The Yale Journal of Biology and Medicine|November 24, 1998
The current status of somatostatin receptors in malignant melanomaW S Fletcher, S S Lum, R W Nance, et al.
Journal of Surgical Oncology|January 1, 1981
Hormone receptors in male breast carcinomaS J Ruff, J E Bauer, E J Keenan, et al.
Journal of the American Academy of Dermatology|September 1, 1988
Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjectsL L Peterson, W R Woodward, W S Fletcher, et al.
Surgery, Gynecology & Obstetrics|June 1, 1990
Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndromeE Mozell, E A Woltering, T M O'Dorisio, et al.
American Journal of Surgery|May 1, 1988
Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremitiesR F Pommier, H S Moseley, J Cohen, et al.
Journal of Cellular Biochemistry|February 3, 2006
Functional and structural properties of stannin: roles in cellular growth, selective toxicity, and mitochondrial responses to injuryM L Billingsley, J Yun, B E Reese, et al.
Pageof 11